• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

neoANT-HILL:一种用于识别潜在新抗原的集成工具。

neoANT-HILL: an integrated tool for identification of potential neoantigens.

作者信息

Coelho Ana Carolina M F, Fonseca André L, Martins Danilo L, Lins Paulo B R, da Cunha Lucas M, de Souza Sandro J

机构信息

Bioinformatics Multidisciplinary Enviroment (BioME), Institute Metropolis Digital, Federal University of Rio Grande do Norte, UFRN, Natal, Brazil.

PhD Program in Bioinformatics, UFRN, Natal, Brazil.

出版信息

BMC Med Genomics. 2020 Feb 22;13(1):30. doi: 10.1186/s12920-020-0694-1.

DOI:10.1186/s12920-020-0694-1
PMID:32087727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7036241/
Abstract

BACKGROUND

Cancer neoantigens have attracted great interest in immunotherapy due to their capacity to elicit antitumoral responses. These molecules arise from somatic mutations in cancer cells, resulting in alterations on the original protein. Neoantigens identification remains a challenging task due largely to a high rate of false-positives.

RESULTS

We have developed an efficient and automated pipeline for the identification of potential neoantigens. neoANT-HILL integrates several immunogenomic analyses to improve neoantigen detection from Next Generation Sequence (NGS) data. The pipeline has been compiled in a pre-built Docker image such that minimal computational background is required for download and setup. NeoANT-HILL was applied in The Cancer Genome Atlas (TCGA) melanoma dataset and found several putative neoantigens including ones derived from the recurrent RAC1:P29S and SERPINB3:E250K mutations. neoANT-HILL was also used to identify potential neoantigens in RNA-Seq data with a high sensitivity and specificity.

CONCLUSION

neoANT-HILL is a user-friendly tool with a graphical interface that performs neoantigens prediction efficiently. neoANT-HILL is able to process multiple samples, provides several binding predictors, enables quantification of tumor-infiltrating immune cells and considers RNA-Seq data for identifying potential neoantigens. The software is available through github at https://github.com/neoanthill/neoANT-HILL.

摘要

背景

癌症新抗原因其引发抗肿瘤反应的能力而在免疫治疗中引起了极大关注。这些分子源于癌细胞中的体细胞突变,导致原始蛋白质发生改变。新抗原的鉴定仍然是一项具有挑战性的任务,主要原因是假阳性率很高。

结果

我们开发了一种高效且自动化的流程来鉴定潜在的新抗原。neoANT-HILL整合了多种免疫基因组分析,以改进从下一代测序(NGS)数据中检测新抗原的方法。该流程已编译到一个预构建的Docker镜像中,下载和设置所需的计算背景最少。neoANT-HILL应用于癌症基因组图谱(TCGA)黑色素瘤数据集,发现了几个推定的新抗原,包括源自复发性RAC1:P29S和SERPINB3:E250K突变的新抗原。neoANT-HILL还用于以高灵敏度和特异性鉴定RNA测序数据中的潜在新抗原。

结论

neoANT-HILL是一个用户友好的工具,具有图形界面,能够高效地进行新抗原预测。neoANT-HILL能够处理多个样本,提供多种结合预测器,能够对肿瘤浸润免疫细胞进行定量,并考虑RNA测序数据以鉴定潜在的新抗原。该软件可通过github获取,网址为https://github.com/neoanthill/neoANT-HILL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb43/7036241/760b548d29b1/12920_2020_694_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb43/7036241/a1c3422eef21/12920_2020_694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb43/7036241/d24bf937b55d/12920_2020_694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb43/7036241/760b548d29b1/12920_2020_694_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb43/7036241/a1c3422eef21/12920_2020_694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb43/7036241/d24bf937b55d/12920_2020_694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb43/7036241/760b548d29b1/12920_2020_694_Fig3_HTML.jpg

相似文献

1
neoANT-HILL: an integrated tool for identification of potential neoantigens.neoANT-HILL:一种用于识别潜在新抗原的集成工具。
BMC Med Genomics. 2020 Feb 22;13(1):30. doi: 10.1186/s12920-020-0694-1.
2
pTuneos: prioritizing tumor neoantigens from next-generation sequencing data.pTuneos:从下一代测序数据中优先选择肿瘤新生抗原。
Genome Med. 2019 Oct 30;11(1):67. doi: 10.1186/s13073-019-0679-x.
3
: Identification of personalized alternative splicing based neoantigens with RNA-seq.利用 RNA-seq 鉴定基于个性化剪接的新抗原。
Aging (Albany NY). 2020 Jul 22;12(14):14633-14648. doi: 10.18632/aging.103516.
4
TSNAdb: A Database for Tumor-specific Neoantigens from Immunogenomics Data Analysis.TSNAdb:一个从免疫基因组学数据分析中获取肿瘤特异性新抗原的数据库。
Genomics Proteomics Bioinformatics. 2018 Aug;16(4):276-282. doi: 10.1016/j.gpb.2018.06.003. Epub 2018 Sep 15.
5
Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.从异常 RNA 剪接中全面分析癌症新抗原。
J Immunother Cancer. 2024 May 15;12(5):e008988. doi: 10.1136/jitc-2024-008988.
6
Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.新抗原的预测与优先级排序:RNA测序数据与全外显子组测序的整合
Cancer Sci. 2017 Feb;108(2):170-177. doi: 10.1111/cas.13131. Epub 2017 Feb 9.
7
ScanNeo: identifying indel-derived neoantigens using RNA-Seq data.ScanNeo:利用 RNA-Seq 数据鉴定移码突变衍生的新抗原。
Bioinformatics. 2019 Oct 15;35(20):4159-4161. doi: 10.1093/bioinformatics/btz193.
8
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens.pVAC-Seq:一种基于基因组引导的计算机模拟方法来鉴定肿瘤新抗原。
Genome Med. 2016 Jan 29;8(1):11. doi: 10.1186/s13073-016-0264-5.
9
TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection.TSNAD:一款用于癌症体细胞突变和肿瘤特异性新抗原检测的集成软件。
R Soc Open Sci. 2017 Apr 5;4(4):170050. doi: 10.1098/rsos.170050. eCollection 2017 Apr.
10
NeoPredPipe: high-throughput neoantigen prediction and recognition potential pipeline.NeoPredPipe:高通量新抗原预测和识别潜力管道。
BMC Bioinformatics. 2019 May 22;20(1):264. doi: 10.1186/s12859-019-2876-4.

引用本文的文献

1
Computational methods and data resources for predicting tumor neoantigens.预测肿瘤新抗原的计算方法和数据资源
Brief Bioinform. 2025 Jul 2;26(4). doi: 10.1093/bib/bbaf302.
2
Transformers meets neoantigen detection: a systematic literature review.变压器与新抗原检测:系统文献综述。
J Integr Bioinform. 2024 Jul 4;21(2). doi: 10.1515/jib-2023-0043. eCollection 2024 Jun 1.
3
Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy.人工智能与新抗原:为精准癌症免疫治疗铺平道路。

本文引用的文献

1
Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade.新抗原与自身蛋白质组的差异预测免疫原性和对免疫检查点阻断的反应。
Cell Syst. 2019 Oct 23;9(4):375-382.e4. doi: 10.1016/j.cels.2019.08.009. Epub 2019 Oct 9.
2
Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.通过 RNA-seq 数据解析揭示的肿瘤免疫微环境的分子和药理学调节剂。
Genome Med. 2019 May 24;11(1):34. doi: 10.1186/s13073-019-0638-6.
3
The Immune Epitope Database (IEDB): 2018 update.
Front Immunol. 2024 May 29;15:1394003. doi: 10.3389/fimmu.2024.1394003. eCollection 2024.
4
GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure.GraphMHC:应用图神经网络进行分子结构分析的新抗原预测模型。
PLoS One. 2024 Mar 27;19(3):e0291223. doi: 10.1371/journal.pone.0291223. eCollection 2024.
5
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges.新抗原靶向的TCR工程化T细胞免疫疗法:当前进展与挑战
Biomark Res. 2023 Dec 1;11(1):104. doi: 10.1186/s40364-023-00534-0.
6
Artificial intelligence applied in neoantigen identification facilitates personalized cancer immunotherapy.应用于新抗原识别的人工智能有助于个性化癌症免疫治疗。
Front Oncol. 2023 Jan 9;12:1054231. doi: 10.3389/fonc.2022.1054231. eCollection 2022.
7
Computational cancer neoantigen prediction: current status and recent advances.计算性癌症新抗原预测:现状与最新进展
Immunooncol Technol. 2021 Nov 20;12:100052. doi: 10.1016/j.iotech.2021.100052. eCollection 2021 Dec.
8
The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies.呈现的重要性:免疫肽组学在表位特异性免疫治疗中的靶标验证。
Front Immunol. 2022 Apr 6;13:883989. doi: 10.3389/fimmu.2022.883989. eCollection 2022.
9
Main Strategies for the Identification of Neoantigens.新抗原鉴定的主要策略。
Cancers (Basel). 2020 Oct 7;12(10):2879. doi: 10.3390/cancers12102879.
免疫表位数据库(IEDB):2018 年更新。
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343. doi: 10.1093/nar/gky1006.
4
Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data.利用RNA测序数据检测癌症基因组中的体细胞突变并进行基准测试。
PeerJ. 2018 Jul 31;6:e5362. doi: 10.7717/peerj.5362. eCollection 2018.
5
MHCflurry: Open-Source Class I MHC Binding Affinity Prediction.MHCflurry:开源的 I 类 MHC 结合亲和力预测。
Cell Syst. 2018 Jul 25;7(1):129-132.e4. doi: 10.1016/j.cels.2018.05.014. Epub 2018 Jun 27.
6
Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.有效筛选识别新抗原的T细胞并构建T细胞受体工程化T细胞。
Oncotarget. 2018 Jan 13;9(13):11009-11019. doi: 10.18632/oncotarget.24232. eCollection 2018 Feb 16.
7
Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy.由个体突变产生的新抗原及其在癌症免疫和免疫治疗中的作用。
Front Immunol. 2017 Nov 28;8:1679. doi: 10.3389/fimmu.2017.01679. eCollection 2017.
8
NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.NetMHCpan-4.0:整合洗脱配体和肽结合亲和力数据的改进的肽与主要组织相容性复合体I类相互作用预测
J Immunol. 2017 Nov 1;199(9):3360-3368. doi: 10.4049/jimmunol.1700893. Epub 2017 Oct 4.
9
TIminer: NGS data mining pipeline for cancer immunology and immunotherapy.TIminer:用于癌症免疫和免疫治疗的 NGS 数据挖掘管道。
Bioinformatics. 2017 Oct 1;33(19):3140-3141. doi: 10.1093/bioinformatics/btx377.
10
TSNAD: an integrated software for cancer somatic mutation and tumour-specific neoantigen detection.TSNAD:一款用于癌症体细胞突变和肿瘤特异性新抗原检测的集成软件。
R Soc Open Sci. 2017 Apr 5;4(4):170050. doi: 10.1098/rsos.170050. eCollection 2017 Apr.